The need of the clinical implementation of pharmacogenetics in European health services for routine drug prescription. What's next? An urgent clinical unmet need for patients

Miquel Taron; Adrián Llerena; Vangelis G Manolopoulos; Cristina Rodriguez-Antona; Sanja Stankovic; Ron H N van Schaik

doi:10.1515/dmdi-2020-0172

The need of the clinical implementation of pharmacogenetics in European health services for routine drug prescription. What's next? An urgent clinical unmet need for patients

Drug Metab Pers Ther. 2020 Nov 13. doi: 10.1515/dmdi-2020-0172. Online ahead of print.

Authors

Miquel Taron^{1

2}, Adrián Llerena^{1

3

4}, Vangelis G Manolopoulos^{3

5}, Cristina Rodriguez-Antona^{1

6

7}, Sanja Stankovic^{3

8}, Ron H N van Schaik^{3

9}

Affiliations

¹ SEFF Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), Madrid, Spain.
² Synlab Diagnósticos Globales SAU, Alcobendas (Madrid), Spain.
³ ESPT European Society for Pharmacogenomics and Personalised Therapy (ESPT), Milano, Italy.
⁴ INUBE Extremadura Biosanitary University Research Institute, Badajoz University Hospital, Pharmacogenetics and Personalized Medicine Unit, Badajoz, Spain.
⁵ Laboratory of Pharmacology, Medical School, Democritus University of Thrace, and Clinical Pharmacology and Pharmacogenetics Unit, Academic General Hospital of Evros, Alexandroupolis, Greece.
⁶ Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
⁷ ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.
⁸ Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.
⁹ Department Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

PMID: 33185569
DOI: 10.1515/dmdi-2020-0172

No abstract available

Keywords: drug prescription; health services; implementation; pharmacogenetics; pharmacogenomics; regulation.

Publication types

Editorial